Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
This company operates as a pharmaceutical company. It engages in drugs and formulation development business
Lyrus Life Sciences Private Limited, is an unlisted private company incorporated on 16 June, 2015. It is classified as a private limited company and is located in , Karnataka. It's authorized share capital is INR 96.25 cr and the total paid-up capital is INR 96.23 cr.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
5.26%
115.58%
-0.45%
7.36%
25.02
12.83
12.63
32.16
12.52
-3.32
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Choose number of credits to buy
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
India
(3)
| State | Type | Address |
|---|---|---|
| Karnataka | Registered Office | No.22, 7th Cross, Jaibharath Nagar, Bangalore, Bangalore, Karnataka, India, 560033 - 560033 |
| Karnataka | Factory, Export | 22, 7th Cross,, Muddappa Road, Jaibharath Nagar, Bangalore, Bengaluru Urban, Karnataka, 560033 |
| Karnataka | Sales Office | Survey 85, Plot No.54A 54B Part, Hosakote Industrial Area, Survey 85,, Kasaba Hobli, Hosakote, Bengaluru Rural, Karnataka, 562114 |
Locations on Map
Filter (4)
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Hemanth Kumar Bothra
Shareholder
|
00033274 | 10 years |
| Director | Leela Kanwar
Shareholder
|
07110887 | 10 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Bank of Baroda
No. of Loans: 1
Total Amount : 30.0 cr
Total Amount : 30.0 cr
Charge Date : 07 Feb, 2025
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NOKHA TRADING PRIVATE LIMITED |
Converted to LLP
|
4.7 Cr | 1 | Karnataka |
| QUALIDAN LIFE SCIENCES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| QUALISYNC PHARMA INNOVATIONS PRIVATE LIM ITED |
Strike Off
|
0.0 | 1 | Karnataka |
| QP HEALTH SERVICES LIMITED |
Active
|
3.5 Cr | 2 | Karnataka |
| NOKHA LIFE SCIENCES LLP |
Active
|
2.0 Cr | 2 | Karnataka |
| ABHILASH LIFE SCIENCES LLP |
Active
|
10.0 Cr | 1 | Nadu |
| PRO-TRUST LLP |
Active
|
1.2 Cr | 1 | Karnataka |
| TRUST CHEMISTS AND DRUGGISTS PRIVATE LIMITED |
Active
|
71.7 Cr | 2 | Karnataka |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| LYRUS LIFE SCIENCES LIMITED, UK | United Kingdom | - | - |
Severe Risk
Moderate Risk
Low Risk
Read more
The incorporation date of LYRUS LIFE SCIENCES PRIVATE LIMITED is 16 June, 2015
The authorized share capital of LYRUS LIFE SCIENCES PRIVATE LIMITED is INR ₹ 96.2 Cr.
The paid-up capital of LYRUS LIFE SCIENCES PRIVATE LIMITED is INR ₹ 96.2 Cr.
The registered address of LYRUS LIFE SCIENCES PRIVATE LIMITED is No.22, 7th Cross, Jaibharath Nagar, Bangalore, Bangalore, Karnataka, India, 560033 - 560033
The CIN number of LYRUS LIFE SCIENCES PRIVATE LIMITED is U24230KA2015PTC080902.
